Gemphire Therapeutics Inc. (GEMP) Is Up Sharply On Study Results
Gemphire Therapeutics Inc. (GEMP) announced after the bell Thursday that its Phase 2b trial of gemcabene met its primary endpoint.
Source: RTTNews
Leading European Football Clubs Announce Participation in New Super League Competition




